Mucopolysaccharidosis Type 1
Rare Disease·MeSH: Stress Disorders, Post-Traumatic
Prevalence
0.5 / 100K
2 drugs in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 1(1)
| Drug | Company |
|---|---|
| sig-005 | Sigilon Therapeutics, Inc. (SGTX) |
Preclinical(1)
Compare drugs
Frequently asked questions
How many drugs are in development for Mucopolysaccharidosis Type 1?
BioSniper tracks 2 drugs in development for Mucopolysaccharidosis Type 1 across 1 company.
How many clinical trials target Mucopolysaccharidosis Type 1?
There are 1 clinical trial targeting Mucopolysaccharidosis Type 1 tracked by BioSniper.
What is the prevalence of Mucopolysaccharidosis Type 1?
The estimated prevalence of Mucopolysaccharidosis Type 1 is approximately 0.5 per 100,000 population.
Deep-dive into Mucopolysaccharidosis Type 1
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis